1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsIdaho Society of Clinical Oncology (ISCO) Community Grants is sponsored by Idaho Society of Clinical Oncology (ISCO). ISCO offers community program grants for Idaho-based nonprofit programs benefiting cancer patients and their families. The programs should align with ISCO's mission of improving hematologic and oncologic care for patients in Idaho.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Idaho Society of Clinical Oncology - ISCO Community Program Grants Idaho Society of Clinical Oncology Yellowstone 2026 Best of ASCO® ISCO Community Program Grants Patient Financial Resources ISCO Corporate Member News ISCO Community Program Grants Idaho Society of Clinical Oncology Community Program Grant Guidelines The Idaho Society of Clinical Oncology (ISCO) is pleased to offer community program grants for Idaho-based nonprofit programs benefiting cancer patients.
ISCO’s Board of Directors will consider funding for a variety of programs that meet ISCO’s mission of improving hematologic and oncologic care of patients in Idaho. The program’s primary mission must be to assist cancer patients and/or their families. Programs must benefit Idaho residents (but can benefit out-of-state residents in addition).
Maximum grant amount is $10,000. As a general rule, ISCO grant awards should not exceed 20% of a program’s budget. Exemptions to this may be made on a case-by-case basis.
Organizations must submit their most-recent 990 form along with the grant application. The 990 form must have been completed within the last 12 months. Grant recipients must be willing to submit a final report within 30 days of the one-year anniversary of the grant award.
Grants will be reviewed and awarded on a rolling basis. Application review and funding recommendations will be made by ISCO’s Board of Directors. Please allow up to 60 days for Board review and response.
Contact IdahoOncology@gmail. com with questions. Please complete and return the application form , along with your most recent 990 form, to IdahoOncology@gmail.
com . P. O.
Box 6332, Boise, ID 83707 | IdahoOncology@gmail. com Powered by Wild Apricot Membership Software
According to the current listing, eligibility includes: Idaho-based nonprofit organizations whose primary mission is to assist cancer patients and/or their families. Programs must benefit Idaho residents, and organizations must submit their most recent 990 form. Confirm the full requirements in the official notice before applying.
The current listing shows up to $10,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Idaho Society of Clinical Oncology (ISCO) Community Grants is funded by Idaho Society of Clinical Oncology (ISCO). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Idaho. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On October 27, 2026, Micron announced more than $67 million for Idaho: $45 million-plus in $250 deposits to 181,000 children's Trump Accounts, $11.6 million for Valley Regional Transit and $10.5 million for housing through LEAP Housing and Boise's Lusk District. The Micron Foundation is not accepting unsolicited proposals. Here is what the split shows about where corporate community dollars are heading.
Read articleRFA-EB-28-004, NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18), puts about $6 million into 8 to 12 BRAIN and HEAL Initiative device-development awards. Budgets should rarely exceed $750,000 in direct costs a year, projects run up to three years, nine institutes participate, and there are six due dates from February 1, 2027 through February 1, 2030. Here is what the program requires and how to write a competitive application.
Read articleSTACK, COMMONS, and CINCH had named primes and September start dates by the time HHS announced them. Evidence Health holds $91.08M of the package; only SURPASS is open, with solution summaries due November 30, 2026.
Read article